Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04085653 |
|---|---|
| Brief Title: | Managed Access Program (MAP) to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS) |
| First Submitted : | September 5, 2019 |
| First Submitted that Met QC Criteria : | September 5, 2019 |
| First Posted : | September 11, 2019 |
| Last Update Submitted that Met QC Criteria : | September 9, 2022 |
| Last Update Posted : | September 14, 2022 |